Barrio, Santiago <br/><br/>
Spectrum and functional validation of PSMB5 mutations in multiple myeloma.  [electronic resource] 

 -  Leukemia  02 2019 
 - 447-456 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/s41375-018-0216-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor--genetics<br/>Boron Compounds--administration & dosage<br/>Bortezomib--administration & dosage<br/>Cohort Studies<br/>Drug Resistance, Neoplasm--genetics<br/>Female<br/>Follow-Up Studies<br/>Gene Expression Regulation, Neoplastic<br/>Glycine--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--drug therapy<br/>Mutation<br/>Neoplasm Recurrence, Local--drug therapy<br/>Oligopeptides--administration & dosage<br/>Prognosis<br/>Proteasome Endopeptidase Complex--drug effects<br/>Survival Rate